FP13.04 KEYNOTE-042 3-Year Survival Update: 1L Pembrolizumab vs Platinum-Based Chemotherapy for PD-L1+ Locally Advanced/Metastatic NSCLC
暂无分享，去创建一个
T. Mok | B. Karaszewska | K. Kubota | G. Lopes | Y. Wu | I. Bondarenko | C. Caglevic | V. Srimuninnimit | I. Kudaba | D. Kowalski | H. Turna | K. Laktionov | F. Souza | B. Cho | L. Yin | J. Lin | Christian Caglevic | Hande Turna | G. Castro | Li Zhang | Boguslawa Karaszewska | Vichien Srimuninnimit